Back

Clinical presentation, risk factors and six-month outcomes in Ugandan women with peripartum cardiomyopathy: prospective case-control study.

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Cardiovascular disease in women (5) Cardiovascular Disease in Women ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Juliet Nabbaale

Uganda Heart Institute, Kampala (Uganda)

6 More presentations in this session

Presentation thumbnail
Endometriosis, a prevalent disease, is associated with significant cardiac disease
Doctor E. Havers-Borgersen (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Influence of persistent atrial fibrillation on the prognosis of heart failure with preserved, mildly reduced, and reduced ejection fraction in women and men.
Professor A. Mansur (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
Evaluation of coronary microvascular dysfunction and vasospasm in patients with angina and non-obstructive coronary artery disease
Doctor O. Quesada (Cincinnati, US)
Abstract Slides Video
Presentation thumbnail
Is the female sex a risk factor for heart failure after myocardial infarction?
Assistant Professor V. Kanic (Maribor, SI)
Abstract Slides Video
Presentation thumbnail
Menopausal status and clinical outcomes in women with heart failure with reduced ejection fraction: the GALACTIC-HF trial
Doctor M. Pabon (Boston, US)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular disease in women (5)

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Clinical characteristics, echocardiographic findings, and six-month outcomes in Ugandan women with peripartum cardiomyopathy: prospective case-control study.
thumbnail
Congress Presentation
Long-term outcomes in women with a history of peripartum cardiomyopathy
thumbnail
Congress Presentation
Survival prospects of women with peripartum cardiomyopathy in Tanzania: a prospective cohort study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources